Dexlansoprazole is a proton pump inhibitor (PPI) used for the treatment of gastroesophageal reflux disease (GERD) and erosive esophagitis. It features a dual delayed-release mechanism that provides prolonged acid suppression by inhibiting the gastric H⁺/K⁺-ATPase enzyme. Dexlansoprazole API is produced under GMP standards and is suitable for oral capsule formulations.

Dexlansoprazole API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.